AIVITA’s lead therapeutic candidate is a patient-specific immunotherapy for the treatment of ovarian cancer. The treatment consists of autologous dendritic cells loaded with antigens derived from tumor-initiating cells. The therapy then is administered through a series of minimally invasive injections over the course of months.

AIVITA’s revolutionary stem cell-derived skin care technology helps address several key signs of skin aging, including the appearance of wrinkles, skin firmness, softness and radiance. AIVITA’s commercial line of skin care product,  PROVOQUETM, is available through authorized physicians.

We are developing novel cell technologies to attain the unrealized potential of stem cell-based therapeutics.


Cancer Immunotherapy

Patient-specific dendritic cell, tumor cell immunotherapy for the treatment of ovarian cancer.

Learn More

Skin Care

A revolutionary stem cell-derived skin care product which helps address several key signs of skin aging.

Learn More